engineered an orally administered E. coli Nissle 1917 probiotic that colonized tumor surfaces in a murine colorectal adenoma model.[25] Upon reaching quorum density, the strain underwent synchronized lysis, locally releasing GM‐CSF, PD‐L1 nanobody, and CTLA‐4 nanobody. This evidence concerns the gene CD274 and neoplasm.